These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 2883024
21. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine. Yanai R, Nagasawa H. J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649 [No Abstract] [Full Text] [Related]
22. Local effects of cholesterol carrier system on binding of lactogens and epidermal growth factor to the developing mammary gland. Vonderhaar BK. Endocrinology; 1993 Jul; 133(1):427-9. PubMed ID: 8319590 [Abstract] [Full Text] [Related]
23. Effects of ergot drugs on prolactin and growth hormone secretion, and on mammary nucleic acid content in C3H-Bi mice. Sinha YN, Selby FW, VanderLaan WP. J Natl Cancer Inst; 1974 Jan; 52(1):189-91. PubMed ID: 4810962 [No Abstract] [Full Text] [Related]
24. The in vitro and in vivo effects of dimethyl sulfoxide on the pituitary secretion of growth hormone and prolactin in mice. Nagasawa H. Ann N Y Acad Sci; 1983 Jan; 411():34-42. PubMed ID: 6192745 [Abstract] [Full Text] [Related]
25. Effects of aristoloside, a component of guan-mu-tong (Caulis aristolochiae manshuriensis), on normal and preneoplastic mammary gland growth in mice. Nagasawa H, Wu G, Inatomi H. Anticancer Res; 1997 Jan; 17(1A):237-40. PubMed ID: 9066658 [Abstract] [Full Text] [Related]
33. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly. Comi RJ, Gorden P. J Clin Endocrinol Metab; 1987 Jan; 64(1):37-42. PubMed ID: 2878009 [Abstract] [Full Text] [Related]
34. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Plewe G, Beyer J, Krause U, Neufeld M, del Pozo E. Lancet; 1984 Oct 06; 2(8406):782-4. PubMed ID: 6148524 [Abstract] [Full Text] [Related]
35. In vivo effect of growth hormone on DNA synthesis and expression of milk protein genes in the rabbit mammary gland. Zebrowska T, Siadkowska E, Zwierzchowski L, Gajewska A, Kochman K. J Physiol Pharmacol; 1997 Dec 06; 48(4):825-37. PubMed ID: 9444628 [Abstract] [Full Text] [Related]
36. Evidence for a mammogenic role of growth hormone in ewes: effects of growth hormone-releasing factor during artificial induction of lactation. Kann G. J Anim Sci; 1997 Sep 06; 75(9):2541-9. PubMed ID: 9303474 [Abstract] [Full Text] [Related]
37. The natural history of prolactin and GH secretion in mice with high and low incidence of mammary tumors. Sinha YN, Selby FW, Vanderlaan WP. Endocrinology; 1974 Mar 06; 94(3):757-64. PubMed ID: 4813677 [No Abstract] [Full Text] [Related]
38. Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Hilakivi-Clarke L, Cho E, Clarke R. Oncol Rep; 1998 Mar 06; 5(3):609-16. PubMed ID: 9538161 [Abstract] [Full Text] [Related]
39. Somatostatin analog treatment of acromegaly: new aspects. Lamberts SW, del Pozo E. Horm Res; 1988 Mar 06; 29(2-3):115-7. PubMed ID: 2900190 [Abstract] [Full Text] [Related]
40. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man. Williams TC, Kelijman M, Crelin WC, Downs TR, Frohman LA. J Clin Endocrinol Metab; 1988 Jan 06; 66(1):39-45. PubMed ID: 2891721 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]